For patients with DCIS, risk of death higher for women under 35, black women
the ONA take:
Women diagnosed with ductal carcinoma in situ have a 20-year breast cancer-specific death rate of 3.3%, with a higher death rate among women diagnosed before age 35 and black women, according to a study published online ahead of print in JAMA Oncology.
For the study, researchers analyzed data from 108,196 women diagnosed with ductal carcinoma in situ of the breast included in the Surveillance, Epidemiology and End Results (SEER) database and compared their risk of dying of breast cancer with that of women in the general population.
Results showed that the 10-year breast cancer-specific death rate after cancer diagnosis was 1.1% and the 20-year rate was 3.3%. Researchers found that women who had a ductal carcinoma in situ diagnosis have a 1.8 times higher risk of death compared those in the general population.
The study also demonstrated that age at diagnosis and black ethnicity were risk factors for death following a ductal carcinoma in situ diagnosis.
Women diagnosed with ductal carcinoma in situ have a 20-year breast cancer-specific death rate of 3.3%.
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Online Learning Modules Improve Exercise Counseling, But Not Participation
- ASCO Issues Statement Addressing Alcohol and Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Drug Combination Does Not Extend Glioblastoma Survival
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|